The Hispanic Paradox: What Does a Mortality Advantage Actually Tell Us?

Part 2 of a series on evidence, measurement, and uncertainty in Latino health.

For decades, Hispanic Americans have often shown lower mortality and longer life expectancy than non-Hispanic White Americans despite, on average, greater socioeconomic disadvantage and barriers to healthcare. [1]

This observation became known as the Hispanic paradox.

When I wrote about it in my first book, Un Doctor Por Favor, what interested me most was not the paradox itself. It was the measurement problem behind it. [2]

We often use mortality as shorthand for health.

But mortality answers one question: How long do people live?

It does not necessarily answer another: How well do they live?

Research published since 2020 has made that distinction much harder to ignore. And the implications extend well beyond Latino health.

Does Living Longer Mean Living Healthier?

The aggregate mortality advantage remains visible.

In 2024, life expectancy at birth was 81.8 years for Hispanic Americans, compared with 78.9 years for non-Hispanic White Americans. [1]

That difference is meaningful.

But life expectancy does not capture disease burden, disability, cognitive function, quality of life, or years lived in good health.

A 2023 study makes the problem especially clear.

At age 50, foreign-born Hispanic women were estimated to live 4.4 years longer overall than White women.

Yet they were also estimated to live 5.3 fewer years with both physical and cognitive function intact. [3]

Same population. Different endpoint. Different conclusion.

A recent review similarly noted that Latino longevity can coexist with substantial burdens of chronic disease, disability, and functional limitation. [4]

So the Hispanic mortality advantage is real if the endpoint is mortality.

The problem begins when we use it to support a broader claim that Hispanics are healthier.

The endpoint can determine the story we tell about a population.

COVID-19 Showed How Context Can Change the Signal

The pandemic provided an unusual stress test.

Before COVID-19, the Hispanic life-expectancy advantage over non-Hispanic Whites was approximately 3.1 years. In 2020, it fell to just 0.5 years. [5]

The decline was not uniform. Some national-origin groups and working-age Hispanic adults experienced particularly large losses, and much of the aggregate advantage later returned as the pandemic evolved. [5,6]

A 2026 county-level analysis found that erosion of the mortality advantage during the first pandemic year was associated with factors including local COVID mortality, lack of insurance, and residential segregation. [7]

That trajectory is difficult to interpret as a fixed characteristic of being Hispanic.

Genomes did not change between 2019 and 2020. Exposures did. Occupational risk changed. Household transmission mattered. Access to protection and care differed. Causes of death shifted.

A population advantage that can contract rapidly when context changes should not be interpreted as a stable biological property.

The same principle matters in clinical research.

A subgroup difference that appears in one setting may weaken, strengthen, or disappear in another.

The question is not only whether the signal exists. It is whether the signal is reproducible across settings.

There Is No Single Latino Health Trajectory

The phrase “Hispanic paradox” creates another problem.

Which Hispanic population?

Recent studies continue to show substantial differences in mortality and healthy aging by heritage, nativity, age, and sex. A 2026 analysis of nearly 1.9 million Latino adults found markedly different patterns of healthy aging across Latino groups, with South American adults generally showing higher levels of preserved physical and cognitive function and Puerto Rican adults among the most disadvantaged. [8]

A major 2023 review reached a similar conclusion: interpretation of the Hispanic health paradox changes substantially when Latino populations are disaggregated by national origin, nativity, age, and health outcome. [9]

That should not be surprising.

“Hispanic” and “Latino” are useful identity and population descriptors. You may read my newsletter edition, published in November of last year, for more information on terminology. These terms do not represent one genetic ancestry, one migration history, one environmental exposure, one socioeconomic trajectory, or one healthcare experience.

The same problem applies to proposed explanations for the paradox.

Researchers have examined healthier immigrant selection, return migration, smoking patterns, social networks, diet, healthcare use, and socioeconomic and environmental conditions. Recent work has not identified one dominant mechanism. Healthcare access and utilization do not fully explain the favorable profiles observed in many foreign-born Latino groups, while other analyses caution against replacing a biological explanation with an overly simple cultural one. [10,11]

That leads to a different possibility:

There may not be one Hispanic paradox.

Several population patterns may be produced by different combinations of migration, behavior, environment, healthcare, social conditions, and measurement, then compressed into one memorable label.

The Comparison Group Can Change the Apparent Advantage

There is another reason to be careful with the word “advantage.”

Advantages are relative.

Part of the apparent advantage may reflect worsening outcomes in the comparison population.

A 2024 analysis examined how deaths involving drugs, alcohol, and suicide contributed to the Hispanic mortality advantage over non-Hispanic White Americans from 1990 through 2019. Their contribution increased over time, particularly among younger adults. [12]

This does not explain the Hispanic mortality advantage as a whole. But it shows why a widening gap should not automatically be interpreted as improving health in the population with lower mortality.

Every population comparison therefore contains information about two populations, not one.

Who we compare, when we compare them, and which outcome we select all influence the conclusion.

Why This Matters for Biomedical Decision-Making

The Hispanic paradox is useful because it exposes four problems that appear repeatedly in biomedical research:

Endpoint selection, population definition, comparator selection, and causal attribution.

Each can change how you interpret the same underlying data.

• If mortality is the endpoint, Hispanic populations may appear advantaged.

• If preserved physical and cognitive function is the endpoint, the advantage can shrink or reverse.

• If heterogeneous Latino populations are combined into one category, clinically meaningful differences may disappear.

• If the comparison population experiences worsening mortality, a relative advantage can widen even without improvement in the population of interest.

These are not abstract methodological concerns.

They affect estimates of disease burden and unmet need.

They shape subgroup analyses and real-world evidence.

They influence biomarker interpretation, external validity, and evidence-generation strategy.

And in biomedical research, they can affect how leaders interpret whether an observed difference is prognostic, predictive, contextual, or simply a consequence of how the population and endpoint were defined.

The broader lesson is simple: Before asking what the data show, ask what the measurement is capable of showing.

A technically correct endpoint can still be incomplete for the decision we are trying to make.

So, What Does the Hispanic Paradox Actually Tell Us?

The Hispanic mortality advantage is real at the aggregate level.

What is much less convincing is the inference that it represents one broadly healthier Latino population with one underlying explanation.

Since writing about the paradox in 2020, I have become less interested in asking: Why do Hispanics live longer?

A better question is: Which Latino populations live longer, compared with whom, how many of those additional years are lived in good health, under what conditions, and what actually explains the difference?

That is a harder question.

It is also a more useful one.

---

References

1. Arias E, Xu J, Tejada-Vera B. United States Life Tables, 2024. National Vital Statistics Reports. 2026;75(5):1–64. doi:10.15620/cdc/252458.

2. Mina-Osorio P. ¡Un Doctor Por Favor!: Why We Need More Hispanic Physicians in the U.S., and Why You Should Be One of Them. New York: Science Education Online; 2020. Chapter 5.

3. Bauldry S, Thomas PA, Sauerteig-Rolston MR, Ferraro KF. Racial-Ethnic Disparities in Dual-Function Life Expectancy. J Gerontol A Biol Sci Med Sci. 2023;78(7):1269–1275. doi:10.1093/gerona/glad059.

4. Goldman N, Pebley AR. The Latino health experience: Past and future. Proc Natl Acad Sci U S A. 2026;123(16):e2530795123. doi:10.1073/pnas.2530795123.

5. Arias E, Tejada-Vera B. Differential impact of the COVID-19 pandemic on excess mortality and life expectancy loss within the Hispanic population. Demographic Research. 2023;48(12):339–352. doi:10.4054/DemRes.2023.48.12.

6. Luck AN, Elo IT, Preston SH, Paglino E, Hempstead K, Stokes AC. COVID-19 and All-Cause Mortality by Race, Ethnicity, and Age Across Five Periods of the Pandemic in the United States. Population Research and Policy Review. 2023;42(4):71. doi:10.1007/s11113-023-09817-8.

7. Zuma BZ, Azizi Z, King S, et al. County-Level Determinants of the Loss of the Hispanic Mortality Advantage in the United States. J Gen Intern Med. 2026;41(11):3087–3094. doi:10.1007/s11606-025-09705-1.

8. García C, Kemp BR, Boen C, Garcia MA. Heterogeneity in healthy aging among U.S. Latinos: a dual functionality perspective. J Gerontol B Psychol Sci Soc Sci. 2026;81(5):gbag039. doi:10.1093/geronb/gbag039.

9. Fernandez J, García-Pérez M, Orozco-Aleman S. Unraveling the Hispanic Health Paradox. Journal of Economic Perspectives. 2023;37(1):145–168. doi:10.1257/jep.37.1.145.

10. Barajas CB, Rivera-González AC, Vargas Bustamante A, et al. Health Care Access and Utilization and the Latino Health Paradox. Medical Care. 2024;62(11):706–715. doi:10.1097/MLR.0000000000002004.

11. Errisuriz VL, Zambrana RE, Parra-Medina D. Critical analyses of Latina mortality: disentangling the heterogeneity of ethnic origin, place, nativity, race, and socioeconomic status. BMC Public Health. 2024;24:190. doi:10.1186/s12889-024-17721-9.

12. Gonzalez Trejo B, Hernandez SM, Lazo M, Bilal U. Contribution of deaths of despair to the Hispanic mortality advantage in the USA by person, place and time: an ecological analysis of vital registration data. BMJ Public Health. 2024;2(2):e001191. doi:10.1136/bmjph-2024-001191.